Skip to main content

Susana Otero Romero

-

Institutions of which they are part

Head of group
Epidemiology and Public Health
Vall Hebron Institut de Recerca
Allergology
General Hospital
Susana Otero Romero

Susana Otero Romero

Susana Otero Romero

Institutions of which they are part

Head of group
Epidemiology and Public Health
Vall Hebron Institut de Recerca
Allergology
General Hospital

-

-

Projects

Características del paciente y del hospital asociadas a la infección nosocomial por microorganismos resistentes a antibiótios - un análisis multinivel

IP: Jose Angel Rodrigo Pendás
Collaborators: Susana Otero Romero
Funding agency: Instituto de Salud Carlos III
Funding: 21175
Reference: PI15/00787
Duration: 01/01/2016 - 30/11/2020

Neuroimmunologia Clínica. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT( (GRC)

IP: Xavier Montalban Gairín
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Sunny Malhotra Sareen, José Ant. Graells Salvador, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Margarida Capell Maymo, Carmen Tur Gomez, Jordi Barquinero Mañez, Herena Eixarch Ahufinger, Carme Santoyo Medina, Oriol Nualart Mundo, Mar Tintore Subirana, M Jesus Arevalo Navines, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Sergio Vergara Ruiz, Luciana Midaglia Fernandez, Joaquin Castillo Justribo, Milagros Fraga Pereira, Breogan Rodriguez Acevedo, Mireia Castillo Juarez, Nicolás Miguel Fissolo, Georgina Arrambide García
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 50000
Reference: 2014 SGR 1082
Duration: 01/01/2014 - 31/12/2016

Development of a universal inFLUenza vaccine based on Tandem CORE technology (FLUTCORE) Grant Agreement nº 602437

IP: -
Collaborators: Jose Angel Rodrigo Pendás, Susana Otero Romero, Xavier Martínez Gómez, Tomàs Pumarola Suñé, Sonia Maria Uriona Tuma, Sonia Maria Uriona Tuma
Funding agency: EUROPEAN COMMISSION
Funding: 81420
Reference: FLUTCORE_FP7HEALTH2013
Duration: 01/09/2013 - 31/03/2017

Red Española de Esclerosis Múltiple

IP: Xavier Montalban Gairín
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Sunny Malhotra Sareen, Jaume Sastre Garriga, Jordi Rio Izquierdo, Fco. Javier Aymerich Martínez, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Carmen Tur Gomez, Cristina Auger Acosta, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Alex Rovira Cañellas, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo
Funding agency: Instituto de Salud Carlos III
Funding: 198090
Reference: RD12/0032/0017
Duration: 01/01/2013 - 31/12/2016

Related news

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment.

El VHIR va participar activament en l'assaig clínic d'aquesta vacuna que avaluava la seguretat, la tolerabilitat i l'eficàcia.

Related professionals

Judit Garriga Segarra

Judit Garriga Segarra

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Raquel Rodríguez Gil

Raquel Rodríguez Gil

Main researcher
Multidisciplinary Nursing Research Group
Read more
Ana Marti Delgado

Ana Marti Delgado

Tècnic/a Grau Superior
Communication Unit
Communication Directorate
Read more
Laura  Rey Sanchez

Laura Rey Sanchez

Research assistant
Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.